WE ARE COMMITTED TO DELIVERING ON PATIENT INSIGHTS, WANTS AND NEEDS.
The biennial IAS Conference on HIV Science is one of the world’s most influential meetings on HIV research. The 2023 event will be held both virtually and in-person in Brisbane, Australia from 23-26 July.
We’re excited to be joining over 8,000 attendees from the medical and HIV communities to present data from across our innovative pipeline and portfolio of medicines. This year, we will be focusing on the importance of patient preference, and addressing the unmet needs of people living with HIV.
One of the key tools to address the preferences of people living with HIV (PLHIV) is to use patient-recorded outcomes (PROs). These measures give insight into areas beyond viral suppression, including health behaviours (drug or alcohol use, or medication adherence), mental health, social wellbeing and life circumstances. PROs are helping healthcare professionals to address unmet needs and preferences by improving their communications with people living with HIV.
In the meantime, watch this space for more detail on our presentations – we’ll update this page as the conference date approaches.
It is now established that if you’re on treatment and have an undetectable viral load, you cannot pass on HIV through sex. Undetectable = Untransmittable, or U=U. This simple equation has profound implications for everyone living with HIV, and for economies and governments around the world.
Discover the importance of representative research for HIV treatment for people living with HIV
We support a growing community of researchers, policy makers, community organisations, advocates and other stakeholders who are interested in studying current HIV care practices.
Our aim is to challenge the status quo, and shape health policy and practices that can lead to an HIV-free future.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.